TLPH Talphera, Inc.
$1.09▲ +0.00%
Healthcare
Other
Volume 60.2K
Avg Volume (10D) 40.5K
Key Metrics & Fundamentals
Market Cap
$56.58M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.69 - 1.57
% vs 50 MA
-5.30%
% vs 200 MA
7.77%
RSI-14
45.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$3.92M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.36M
COGS
–
Operating Exp
$3.92M
Operating Income
-$3.92M
EBIT
-$3.92M
Pretax Income
-$4.31M
Net Income
-$4.31M
EPS (Diluted)
-0.06
Price & Volume History
Loading chart…
Recent News
Talphera (TLPH) Upgraded to Buy: Here's What You Should Know
Zacks · Sep 21, 2026 12:00 PM ET
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 3, 2026 8:30 AM ET
Talphera (TLPH) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 5:28 PM ET
Talphera, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 9:30 PM ET
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO Study Enrollment Hits 75% as ...
GuruFocus.com · Aug 13, 2026 1:03 AM ET
Talphera Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 11:04 PM ET
Talphera: Q2 Earnings Snapshot
Associated Press · Aug 12, 2026 4:11 PM ET
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · Aug 12, 2026 4:05 PM ET
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
PR Newswire · Aug 5, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Sep 2025
See TLPH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.